Impact of enzymatic and toxic potentiality of Aspergillus species to cause aspergillosis

M. Adam (ASSIUT, Egypt)

Source: International Congress 2017 – Management of asthma in different situations
Session: Management of asthma in different situations
Session type: Thematic Poster
Number: 3580
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Adam (ASSIUT, Egypt). Impact of enzymatic and toxic potentiality of Aspergillus species to cause aspergillosis. 3580

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of enzymes and toxins potentiality of four Aspergillus species to cause aspergillosis
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Frequency of candida species mycoses isolation from patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 422s
Year: 2004

Influence of candida species fungi on growth and pathogenicity of mycobacteria tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 663s
Year: 2007

Parasexual recombination enables Aspergillus fumigatus to persist in cystic fibrosis
Source: ERJ Open Res, 6 (4) 00020-2020; 10.1183/23120541.00020-2020
Year: 2020



Performance of Siemens immulite immunoassay for detection of Aspergillus fumigatus and Aspergillus flavus specific IgG for chronic pulmonary aspergillosis diagnosis in Pakistan
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Allergic bronchopulmonary aspergillosis and other fungal diseases
Source: Eur Respir Mon 2011; 52: 97-114
Year: 2011


Volatile organic compounds emitted by pseudomonas aeruginosa and aspergillus fumigatus mono-cultures and in co-culture
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Aspergillus and other fungi
Source: School Course 2012 - Lung Transplantation
Year: 2012



Aspergillus and other fungi
Source: ERS Course 2016
Year: 2016




Tracheal oxalosis associated with Aspergillus niger tracheobronchitis
Source: Eur Respir J 2013; 41: 995-997
Year: 2013


Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Evidence for local IgE production to Aspergillus fumigatus in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


The contribution of Aspergillus fumigatus to COPD exacerbations: a “sensitive” topic
Source: Eur Respir J, 56 (2) 2002223; 10.1183/13993003.02223-2020
Year: 2020



Clinical application and radiological relavance for Aspergillus fumigatus- and flavus-specific IgG in chronic Pulmonary Aspergillus infection>
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Role of Aspergillus infection in uncontrolled Asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018



Global burden of chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J 2013; 41: 621-626
Year: 2013